Confronting Scientists ' Normal Ethical Dilemmas

The recent furor over fabricated data in a paper of which Nobel laureate David Baltimore is a coauthor raises serious questions about the scientific community's approach to ethical issues. It also provides an opportunity for scientists to acknowledge and confront a broad array of ethical dilemmas that will never attract media attention, but can undermine science as much as the blatant violations that do make headlines. Many scientists' reactions to media accounts of scientific misconduct are

Written byMichael Greenberg
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

The recent furor over fabricated data in a paper of which Nobel laureate David Baltimore is a coauthor raises serious questions about the scientific community's approach to ethical issues. It also provides an opportunity for scientists to acknowledge and confront a broad array of ethical dilemmas that will never attract media attention, but can undermine science as much as the blatant violations that do make headlines.

Many scientists' reactions to media accounts of scientific misconduct are based on the assumption that some elected officials, disenchanted researchers, or journalists are behind the gossip--trying to advance themselves by destroying the career of one eminent scientist or another. They assume that scientists in general are basically ethical people who simply need to be more aware of constantly changing legal requirements, improve their housekeeping practices, maybe attend a seminar or two on ethics, and pay closer attention to the work of their junior colleagues. ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies